August 25, 2025

Alkermes plc (ALKS) Stock Analysis: A 39.5% Potential Upside Captures Investor Attention

Alkermes plc (ALKS), a Dublin-based biopharmaceutical company, is garnering significant interest from the investment community. With a market capitalization of $4.91 billion, the company operates in..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring an 82.61% Upside Potential

Investors looking for growth in the healthcare sector may want to turn their attention to Telix Pharmaceuticals Limited (TLX), a promising player in the biotechnology industry..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating a 55.5% Revenue Growth in the Biotechnology Sector

Blueprint Medicines Corporation (NASDAQ: BPMC) has garnered attention within the biotechnology sector, particularly for its impressive revenue growth of 55.5%. This Cambridge, Massachusetts-based precision therapy company..

Align Technology, Inc. (ALGN) Stock Report: Exploring a 24.60% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Tempe, Arizona,..

STERIS plc (STE) Stock Analysis: A Healthcare Giant with 8.14% Potential Upside

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, particularly within the medical devices industry, stands as a compelling investment opportunity with a market..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotech with a 68.4% Revenue Growth and 18.3% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a key player in the biotechnology sector, is attracting investor attention with its robust revenue growth and intriguing market potential. Specializing in..

ICON plc (ICLR) Investor Outlook: Navigating a 23% Upside Potential Amidst Market Volatility

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, has caught the attention of investors with its promising potential upside of 23.30%...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating the Healthcare Sector with Modest Upside and Strategic Vision

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. With a market cap of approximately..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Growth Potential with a 5.33% Upside

Qiagen N.V. (QGEN) stands out in the diagnostics and research industry, strategically positioned at the intersection of healthcare and technology. Headquartered in Venlo, Netherlands, Qiagen is..

Avidity Biosciences, Inc. (RNA): Exploring a 44.55% Upside in Biotech Innovation

Investors looking for opportunities in the biotechnology sector might find Avidity Biosciences, Inc. (NASDAQ: RNA) an intriguing candidate, especially given its potential upside of 44.55% according..

Halozyme Therapeutics, Inc. (HALO) Stock Report: Analyzing the Biotech Leader’s 179% ROE and Revenue Growth Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the healthcare sector as a biopharmaceutical company with a robust pipeline and impressive financial metrics that pique investor..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Strong Buy Ratings Amidst 66.80% Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a notable player in the biotechnology sector focusing on rare neuroendocrine diseases, has captured the attention of investors with its impressive..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) is a formidable player in the healthcare sector, focusing on medical distribution. With a market capitalization of $8.44 billion, the company..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a Promising 16% Upside Potential

GE HealthCare Technologies Inc. (GEHC), a formidable player in the Healthcare sector, continues to command attention with its innovative strides in health information services. The company,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising 36% Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS) stands out in the biotechnology sector with a market capitalization of $4.36 billion, making it a notable contender in the healthcare..

Alnylam Pharmaceuticals Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with Diverse Pipeline and High Valuation

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, boasting a market capitalization of $59.56 billion. Known for pioneering therapeutics based..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech Contender with 52% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical firm, is currently making waves in the biotechnology sector. With a market capitalization of $5.49 billion, Nuvalent is focused..

Fresenius Medical Care AG (FMS) Investor Outlook: Navigating a 20.78% Upside Potential in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, stands poised for potential growth within the medical care facilities industry. Headquartered in..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Healthcare Diagnostics with a $27.22 Billion Market Cap

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable player within the healthcare sector, specifically in the diagnostics and research industry. With a substantial market capitalization..

Akero Therapeutics (AKRO) Investor Outlook: Analysts See 54.93% Upside Potential

Investors eyeing Akero Therapeutics, Inc. (NASDAQ: AKRO) will find a compelling case for potential growth, driven by the company’s focus on breakthrough treatments for serious metabolic..

Search

Funds

August 25, 2025

Search

Funds

August 25, 2025

FTSE 100

Funds